 |
Previous Article | Next Article 
The Journal of Neuroscience, October 1, 1999, 19(19):8367-8376
Optic Nerve Crush: Axonal Responses in Wild-Type and bcl-2
Transgenic Mice
Sabrina
Chierzi1 2,
Enrica
Strettoi1 ,
Maria
Cristina
Cenni1 , and
Lamberto
Maffei1 2
Istituto di Neurofisiologia del Consiglio Nazionale delle Ricerche,
and 2 Scuola Normale Superiore, 56127 Pisa, Italy
 |
ABSTRACT |
Retinal ganglion cells of transgenic mice overexpressing the
anti-apoptotic protein Bcl-2 in neurons show a dramatic increase of
survival rate after axotomy. We used this experimental system to test
the regenerative potentials of central neurons after reduction of
nonpermissive environmental factors. Survival of retinal ganglion cells
1 month after intracranial crush of the optic nerve was found to be
100% in adult bcl-2 mice and 44% in matched wild-type (wt)
mice. In the optic nerve, and particularly at the crush site, fibers
regrowing spontaneously or simply sprouting were absent in both wt and
bcl-2 mice. We attempted to stimulate regeneration implanting in the
crushed nerves hybridoma cells secreting antibodies that neutralize
central myelin proteins, shown to inhibit regeneration (IN-1
antibodies) (Caroni and Schwab, 1988 ). Again, we found that regeneration of fibers beyond the site of crush was virtually absent in
the optic nerves of both wt and bcl-2 mice. However, in bcl-2 animals
treated with IN-1 antibodies, fibers showed sprouting in the proximity
of the hybridoma implant. These results suggest that neurons
overexpressing bcl-2 are capable of surviving axotomy and sprout when
faced with an environment in which inhibition of regeneration has been
reduced. Nevertheless, extensive regeneration does not occur, possibly
because other factors act by preventing it.
Key words:
survival; axotomy; regeneration; sprouting; bcl-2; myelin
 |
INTRODUCTION |
In the adult CNS of mammals,
regeneration of transected axons is usually absent. The main reasons
are usually ascribed to the massive death of damaged neurons and to the
inhibitory role exerted by CNS.
The optic nerve is a suitable CNS model to approach the problem of
regeneration. Its transection leads to the fast and massive death of
axotomized retinal ganglion cells (RGCs) (Villegas-Perez et al., 1988 ;
Berkelaar et al., 1994 ). Several strategies have been followed to
increase their survival (Carmignoto et al., 1989 ; Thanos et al., 1989 ;
Maffei et al., 1990 ; Mansour-Robaey et al., 1994 ); recently, we showed
the protecting effects of the anti-apoptotic gene bcl-2 on axotomized
RGCs (Bonfanti et al., 1996 ; Cenni et al., 1996 ).
The upregulated expression of bcl-2 prevents neuronal death in several
in vitro systems (Allsopp et al., 1993 ; Zhong et al., 1993 ). The efficacy of bcl-2 in promoting neuronal survival
in vivo has been evaluated by means of a transgenic mouse
overexpressing the bcl-2 gene in neurons (Martinou et al., 1994 ); 2 months after the transection of the optic nerve, 63% of retinal
ganglion cells survive in the bcl-2 mouse, whereas survival in the wild
type (wt) is 5%. The proximal segments of injured axons, at least near to the optic nerve head, is also preserved (Cenni et al., 1996 ); light
responses in RGCs are maintained as well (Porciatti et al., 1996 ).
Among the numerous attempts to counteract the process of ganglion cell
death after optic nerve lesion, bcl-2 overexpression is by far the most
successful strategy.
We asked whether axotomized RGCs of bcl-2 transgenic mice are able to
regrow their severed fibers in vivo across the lesion site.
This question seemed particularly relevant in view of recent findings
supporting the notion that the bcl-2 gene is implicated in neuronal
differentiation (Middleton et al., 1998 ), rate of axonal elongation
(Hilton et al., 1997 ), and duration of cell cycle steps (Adams and
Cory, 1998 ). In addition, it has been reported that cultured RGCs from
adult bcl-2 mice retain the ability of growing their processes on
embryonic tectal slices (Chen et al., 1997 ).
To study regeneration in the optic nerve, the strong hostility of
mature CNS to axonal elongation has to be counteracted. Experiments
in vivo show that mammalian RGCs are indeed capable of
regenerating their axons through transplants of peripheral nerves
(Vidal-Sanz et al., 1987 ). Inhibitory molecules have been identified that arrest growth cone progression; in particular, a 250 kDa protein fraction, purified from CNS myelin, exerts a powerful antagonistic effect on axonal growth; the monoclonal antibody
IN-1, raised against this fraction (Caroni and Schwab, 1988 ), is
capable of effectively counteracting the inhibitory action of CNS
myelin, allowing neuronal regeneration in many different CNS areas (for
review, see Brösamle and Schwab, 1996 ).
In this study, we made use of the IN-1 antibody to create a less
hostile environment for fiber regrowth; we crushed the optic nerve of
wt and bcl-2 mice and implanted hybridoma cells secreting the IN-1
antibody in the proximity of the damaged nerve. We report the effects
of such treatment 1 month after crush.
 |
MATERIALS AND METHODS |
Animals. Transgenic mice from the NSE73a line,
developed by J-C Martinou (Serono, Geneva, Switzerland), were used in
the present study as in previous studies (Cenni et al., 1996 ; Chierzi
et al., 1998 ). These mice overexpress the human protein Bcl-2 in
neurons under the control of neuron-specific enolase. Characteristics of the transgenics are reported in Martinou et al. (1994) . Briefly, our
colony started in 1994 from an heterozygous bcl-2 male founder of the
NSE73a line crossed with a female of the C57BL6/J strain (The Jackson
Laboratory, Nossan, Milan, Italy); the colony was developed by
selecting transgenic males from offspring and crossing them over with
nontransgenic C57BL6/J females; bcl-2 females have a closed vagina and
cannot be used for reproduction. The presence of the transgene was
detected by PCR on DNA extracted from tail tissue of animals.
The presence of the human Bcl-2 protein was occasionally revealed by
immunohistochemistry on retinal tissue using the anti-human bcl-2
antibody from Dako (Milan, Italy) (clone 124); high density of retinal
ganglion cells and large size of the optic nerves confirmed a typical
bcl-2 phenotype. Mice used as controls were C57BL6/J of the same
litters but bcl-2-negative. A total number of 36 mice were used in this
study; they ranged in age between 3 and 6 months.
Hybridoma cells. Mouse hybridoma cells producing IN-1
antibody (clone IN-1 C4) and control hybridoma cells producing
antibodies against HRP (clone HRP 4HI) were used. Details about clone
isolation and culturing conditions are given by Caroni and Schwab
(1988) . Before surgery, cells were thawed and resuspended at a
concentration of 50,000 cells/ml and grown in culture for 4-5 d in
Iscove's medium supplemented with 6% fetal bovine serum, 2 mM L-glutamine, 100 U/ml
penicillin-streptomycin, and 50 mM
-mercaptoethanol. Before implantation, the supernatants of all the
hybridoma cells used were tested for the production of mouse IgM (in
the case of IN-1 C4) or IgG (in the case of HRP 4HI), by using the
assay Boehringer Mannheim (Milan, Italy) IsoStrip. IN-1 supernatant was
also used to immunostain the NI 250 fraction of myelin in the intact
mouse optic nerve and tract. The staining, revealed with anti-mouse
FITC secondary antibodies (dilution of 1:200; Sigma, Milan, Italy), was
very intense throughout the optic pathway.
Surgery. The animals were deeply anesthetized with
Avertin (1.2% tribromoethanol and 2.4% amylene hydrate in
distilled water, 2 ml/100 gm body weight), and the left optic nerve was
crushed mechanically with thin surgical forceps. The crush was
performed intracranially, ~3 mm from the posterior pole of the eye;
special care was taken to avoid mechanical damage to the retinal
artery. We used three different experimental protocols: simple crush of the optic nerve (six wt and seven bcl-2 animals used); crush plus injection of IN-1 hybridoma cells (six wt and six bcl-2 used); crush of
the optic nerve plus injection of HRP antibodies (four wt and three
bcl-2 used).
Hybridoma injection. Six wt and six bcl-2 mice received an
injection of IN-1, producing hybridoma cells directly into the lesioned
nerve at the site of the crush operation. Approximately 3-5 × 105 cells in 1 ml of HBSS were
injected using a glass pipette pulled to a final tip of 20-30 µm
driven by an oil microinjector. Hybridoma cells were prestained with
DiI (2 mg/ml in DMSO per milliliter of HBSS) to allow further
recognition. Control experiments were performed injecting in the
crushed nerves hybridoma cells producing antibody against HRP.
Histology. Four weeks after surgery, the left eyes of the
operated animals were injected with 2 µl of 20% neurobiotin tracer (Vector Laboratories, Burlingame, CA) in saline solution. One day after
neurobiotin injection, the animals were perfused transcardially with
4% paraformaldehyde in 0.1 M phosphate buffer;
both optic nerves were carefully dissected, rinsed, cryoprotected with
30% sucrose, and flat frozen on a cryostat stage. Consecutive frozen sections were cut at 12 µm thickness and reacted with 1:400
avidin-FITC to visualize neurobiotin. Adjacent sections were
immunostained with antibodies against the 200 kDa subunit of
neurofilaments (clone N52; dilution of 1:200; Sigma) to allow
visualization of the whole fiber population (Berry et al., 1996 ; Burne
et al., 1996 ). Selected sections were immunostained using the F4/80 rat monoclonal antibody (dilution of 1:10; Serotec, Oxford, UK) specific for mouse microglia and macrophages (Austyn and Gordon, 1981 ). Secondary antibodies were tetramethylrhodamine
isothiocyanate-anti-mouse IgG (Sigma, dilution 1:50) and Alexa
488-anti rat IgG (dilution of 1:400; Molecular Probes, Eugene, OR), respectively.
The whole series of sections obtained from each nerve was examined
systematically with an Zeiss (Milan, Italy) Axioplan microscope equipped with epifluorescence. Representative sections were analyzed in
detail with a Leica (Milan, Italy) TCS-NT confocal microscope. Confocal
series were obtained through the whole section thickness (10-12 µm);
each focal series was visualized as a projection on single plane.
The optic nerves of two wt and two bcl-2 mice that had received a
simple crush were post-fixed in 4% glutaraldehyde in 0.1 M
phosphate buffer for 12 hr. Subsequently, each nerve was dissected transversally in four blocks, from the optic nerve head to the optic
chiasm, which were processed separately; one block contained the optic
nerve head and another the crush site, which was readily recognizable
under the dissecting scope for its yellowish, transparent appearance.
Nerve blocks were treated with 2% osmium tetroxide, stained with 1%
uranyl acetate in maleate buffer, dehydrated in ethanol, and embedded
in Epon-Araldite. Semithin sections, 1- to 2-µm-thick, were
cut with a diamond knife from the blocks containing the optic nerve
heads and from those containing the lesion site, sectioned from its
proximal side. Sections were stained with Epoxy Tissue Stain (Electron
Microscopy Sciences, Fort Washington, PA) and examined with a Zeiss
Axioplan photomicroscope.
Survival. The left retinas of three wt and three bcl-2
animals that had received crush of the left optic nerves 4 weeks
before, plus the retinas of three wt that had received an injection of IN-1 hybridoma cells, were stained as whole mounts with 2 mM ethidium homodimer II (Molecular Probes) and
examined at the confocal microscope. The total number of cells in the
ganglion cell layer (GCL) was estimated from counting 16-20 regularly
spaced 125 × 250 µm fields located in the four retinal
quadrants and multiplying the average cellular densities to the retinal
areas measured with an image analyzer (Imaging Inc., Ontario, Canada).
The number of displaced amacrines and ganglion cells in the intact
retinas of wt and bcl-2 mice were obtained from separate studies (Cenni
et al., 1996 ; Jeon et al., 1998 ). Survival was estimated by subtracting
the number of displaced amacrines from the total number of cells found in the GCL 1 month after surgery; the obtained values were expressed as
a fraction of the number of GCs of the intact retinas.
Quantification of sprouting. A total of 20 nerves in which
fibers were stained with neurobiotin were used to obtain a
semiquantitative evaluation of axonal sprouting. Animals were
distributed in the following groups: three wt mice that had received a
simple crush (wt-crush); three bcl-2 mice with simple crush (bcl-2
crush); three wt mice with crush plus injection of HRP-hybridoma cells (wt HRP); three bcl-2 mice with crush plus HRP-hybridoma cells (bcl-2
HRP); three wt mice with crush plus IN-1-hybridoma cells (wt IN-1); and
three bcl-2 mice with crush plus IN-1 hybridoma cells (bcl-2 IN-1). For
each crushed nerve, representative sections were analyzed at the
confocal microscope as described above. Images representing projections
of nerve sections near the crush site were transferred on a
microcomputer imaging device (Imaging, Inc.) M4 image analyzer. The
intensity of fluorescence staining of fibers was determined by means of
densitometric analysis at 10 different spots, spaced regularly along
two selected lines perpendicular to the major axis of the nerve
section. The first line corresponds to the border of the transected
fibers (the virtual edge at which the majority of fibers stops); the
second line is taken at a more proximal position (within a distance of
300 µm from the first line, toward the optic nerve head). At each
location, in each section, we calculated the ratio between the optical
density (OD) measured at the first line and the OD at the second line,
respectively. This value is referred to as ODR (optical density ratio).
 |
RESULTS |
Effects of crush lesion in wt and bcl-2 mice 1 month
after surgery
Figure 1 reports the fractions of
surviving retinal ganglion cells in adult wt and bcl-2 mice (three
retinas for each strain) 1 month after intracranial crush of the optic
nerve. In the wt, optic nerve crush results in the survival of
approximately half retinal ganglion cells (44%). On the other hand, in
the bcl-2 mouse, virtually 100% of RGCs are still alive. This confirms
the powerful survival-promoting effect of the bcl-2 gene.

View larger version (74K):
[in this window]
[in a new window]
|
Figure 1.
Survival rate of retinal ganglion cells 1 month
after intracranial crush of the left optic nerve.
Columns are percentage average survivals with error
bars. The first column refers to wild-type retinas
(n = 3) and the second column to
bcl-2 retinas (n = 3). Notice that survival is
100% in bcl-2 animals. The last column shows the
survival rate of ganglion cells in wt retinas (n = 3) after injection of IN-1 hybridoma cells at the site of crush.
|
|
Figure 2 shows the effects of crush
lesion onto optic fiber preservation in wt and bcl-2 optic nerves in
transversal semithin sections (two nerves examined for each strain).
Both optic nerves are illustrated at the emergence from the posterior
pole of the eye and at the crush site, respectively. At the optic nerve
head, individual degenerating fibers are visible: however, the overall nerve structure is still well preserved, especially in the bcl-2 mouse
(Fig. 2A-D). Toward the crush site, fibers with
disorganized morphology become more evident, in both the wt and the
bcl-2 nerve (Fig. 2E,F).
Axons have retracted and a central core of vacuolization, and tissue
reorganization has appeared. Higher magnification of the lesion site
shows individual dying fibers all over the whole nerve surface; in the
bcl-2, normal fibers are still visible, mostly in the superficial ring
of the nerve (Fig. 2G,H). When crushed optic nerves are analyzed in longitudinal sections after neurobiotin injection in the corresponding eyes, individual fibers are
visualized along their course to the lesion point (Fig.
3). After crush, fibers end at different
positions along the longitudinal axis of the nerve, depending on the
variable extent of retraction. We define as "border of the fibers"
the line (perpendicular to the longitudinal axis of the nerve) at which
the majority of axons stops. This line represents one of the boundaries
we used for densitometric analysis (see below). It is important to
point out that, 1 month after crush, there is no spontaneous sprouting
of the fibers or elongation beyond the border, in both the wt and bcl-2
nerves (four nerves examined in longitudinal serial sections for each
strain of mice).

View larger version (175K):
[in this window]
[in a new window]
|
Figure 2.
Light micrographs of the optic nerves of bcl-2
(left) and wild-type (right) mice 1 month
after intracranial crush. A, B, Sections
obtained in the proximity of the optic nerve head. C,
D, High magnifications of A and
B, respectively. The general morphology is well
preserved in both wt and bcl-2 (A, B);
degenerating fibers, characterized by a disorganized myelin sheath, are
rare in the bcl-2 and more abundant in the wt (arrows in
C and D). E,
F, Sections obtained near the crush site and proximal to
it. At low magnification, a central core of degeneration is evident in
the bcl-2 nerve (arrows in E). At higher
magnification, vacuoles are visible in the nerve core of the bcl-2
(arrows in G); however, numerous fibers
appear still viable at more superficial positions (top
of G). In the nerve of the wt (F,
H) degeneration of fibers is widespread, as
clearly illustrated in H; arrows point to
altered myelin. Scale bars: (in A, E)
A, B, E, F,
100 µm; (in C, G) C,
D, G, H, 20 µm.
|
|

View larger version (78K):
[in this window]
[in a new window]
|
Figure 3.
Longitudinal sections of wt
(A) and bcl-2 (B) nerves
shown near the crush site (arrows) after neurobiotin
injection in the corresponding eyes. This and the following images have
been obtained at the confocal microscope as explained in Materials and
Methods. The optic nerve head is located to the left.
Note that, in both cases, resilient fibers fail to pass beyond the
crush site and do not sprout.
|
|
Effects of IN-1 hybridoma cell injections
To create a favorable environment to optic fiber regeneration, we
injected in the optic nerves hybridoma cells producing an antibody
(IN-1) known to bind and neutralize a powerful inhibitor of fiber
elongation associated with CNS myelin (NI-250).
Injection of 1 µl of suspension containing 3-5 × 105 cells was performed in the crushed
optic nerves of mice. The supernatant of IN-1 hybridoma cells was
tested for the production of mouse IgM before each injection. The
actual number of cells injected can be expected to vary to some extent,
because some of the suspension was observed to flow out from the nerve
after pipette withdrawal. The successful outcome of the injection was
tested at the time of nerve dissection; hybridoma cells, labeled with
DiI could be visualized with a fluorescence microscope in the intact
nerves and are visible in Figures 4 and
5 in longitudinal nerve sections. One
month after crush, hybridoma cells appeared mostly concentrated near
the injection site without remarkable migration inside the nerve. To
check whether IN-1 hybridoma injection could exert some effect in
preventing neuronal cell death, we computed the number of resilient
ganglion cell in the retinas of three wt mice treated with IN-1
antibody. In these animals, RGC survival was in the same range (54%)
observed in the case of wt mice with a simple crush lesion (Fig. 1).
Consequently, in our system, we can exclude a role of IN-1-producing
hybridoma cells in affecting neuronal survival.

View larger version (62K):
[in this window]
[in a new window]
|
Figure 4.
Longitudinal sections of crushed optic nerves of
bcl-2 (A) and wt (B) mice 1 month after ON crush and implantation of IN-1 hybridoma cells. Fibers
are labeled green by neurobiotin injected into the eye
and revealed with FITC-avidin. Hybridoma cells, stained with DiI,
appear red. Arrows point to the crush
site. C, Staining with F4/80 antibody, specific for
mouse microglia and macrophages. Double-labeled cells (short
arrow) are immunopositive cells that have engulfed DiI, and the
red ones are hybridoma cells (long
arrow).
|
|

View larger version (89K):
[in this window]
[in a new window]
|
Figure 5.
High magnification of bcl-2
(A) and wt (B) nerves
illustrated at the site of crush. Arrows indicate the
lesion site. Note the wealth of sprouting profiles in the bcl-2
(A) compared with the paucity of fibers present
in the wild type (B). White
squares are examples of the points intersected by lines
perpendicular to the nerve major axes and used to calculate the density
values of fluorescence staining. The square on the
left is at the sprouting site, and the
right one is located more proximally. C,
The tip of a regenerating fiber from A exhibits the
typical morphology of a growth cone (arrow).
|
|
The effects of IN-1 on crushed fibers were evaluated after systematic
examination of longitudinal sections of optic nerves after neurobiotin
injection in the corresponding eyes. In both wt and bcl-2 (six animals
for each strain), we observed that the majority of fibers that reached
the crush site interrupted abruptly (Fig.
4A,B). Only in the case of one
bcl-2, fibers were seen to regrow for ~500 µm beyond the major
border of fibers. Elongation occurred in axons running at the surface
of the optic nerve. In all the remaining cases, fibers did not succeed
in growing more than 10-20 µm. We can conclude that, despite of the
administration of IN-1 hybridoma cells in the lesion area, we did not
observe any significant regeneration.
On the other hand, we observed a sprouting promoting effect after
injection of IN-1 hybridoma cells; in all bcl-2 mice, we found fibers
that sprouted at the lesion site. Figure 5A shows the
longitudinal section of one of these nerves in which sprouting is
particularly profuse. Fibers appear green, and DiI-stained hybridoma cells are red. Many axon terminals can be seen at
the site of crush (indicated by arrows); some of them show
large size and intense staining, as is typical of degenerating fibers,
although the majority are thin and sprout profusely. Sprouting
processes have often a tortuous course with ramifications. Similar
sprouting profiles, in variable number and degree of complexity, could
be observed in all the IN-1-treated bcl-2 mice. Immunocytochemistry with an antibody against the heavy subunit of neurofilaments showed that large-sized degenerating fibers were intensely stained, whereas the thinner ones, exhibiting a tortuous course revealed by neurobiotin injection, were usually not labeled. The absence of neurofilament staining in processes with morphology typical of newly formed fibers
confirms that they are sprouting axonal terminals. It has been shown
that the heavy subunit of neurofilaments is absent from the tips of
actively growing axons (Foster et al., 1987 ).
Figure 4B also shows the result of the injection of
IN-1-producing hybridoma cells in crushed nerves of wt mice. As can be observed at high magnification (Fig. 5B), most of the axons
in the wt end freely at the border of fibers, without obvious
ramifications. Retraction is evident. A quantitative analysis of fiber
behavior in various experimental groups is illustrated later and
includes an evaluation of the sprouting effect.
Control experiments
Control experiments were performed injecting in the crushed nerves
of four bcl-2 and three wild-type mice hybridoma cells producing
antibodies against HRP; cell injections followed the same protocol used
for IN-1 hybridoma cells. Longitudinal sections of the nerves were
examined systematically after neurobiotin injections in the eyes.
Results are shown in Figure 6. Axons
behaved mostly as in the case of a simple crush; namely, they stopped
at the lesion site without sprouting or elongating, in both wt and
bcl-2 animals. Retraction at the lesion site was again visible. We
concluded that the injection of hybridoma cells that do not release
antibodies interfering with axonal elongation is not sufficient per se
to promote sprouting in bcl-2 mice.

View larger version (74K):
[in this window]
[in a new window]
|
Figure 6.
Longitudinal sections of wt
(A) and bcl-2 (B) nerves
that have received an injection of HRP hybridoma cells at the site of
crush. Fibers stop at the lesion site, indicated by
arrows.
|
|
In addition, we looked for major differences between wt and bcl-2 in
the macrophage-microglia response to crush after hybridoma cell
injection. Figure 7 shows F4/80 staining
in crushed nerves of wt and bcl-2 that had received an injection of HRP
cells. The staining revealed numerous cells, identifiable as
macrophages because of their large size, scattered all over the nerves,
although mostly concentrated at the lesion site. They stained so
intensely that small-sized microglial cells were primarily obscured.
F4/80-positive cells of similar morphology were absent from the
contralateral, intact nerves in which only microglia was labeled. There
were no evident differences between wt and bcl-2 mice in the F4/80 pattern of immunoreactivity. Thus, we can expect that
macrophage-microglia recruitment follows similar rules in the two
cases. However, this issue can be clarified only after a systematic
analysis of the immune response after optic nerve crush in the two
strains of mice, similar to the study of Lawson et al. (1994) . Because
this was beyond the scope of this study, we did not make any attempt to
go into further details.

View larger version (153K):
[in this window]
[in a new window]
|
Figure 7.
F4/80 staining in crushed nerves of wt
(A) and bcl-2 (B) that had
received an injection of HRP cells. The crush site is indicated by
arrows. Stained cells are dense at the lesion site;
C and D (enlargements of the fields shown
as rectangles in A and B)
illustrate large size cells having a round morphology, typical of
macrophages. Notice that there are not obvious differences in the
staining between A and B.
|
|
Semiquantitative evaluation of fiber sprouting
We tried to express quantitatively the extent of sprouting,
performing OD measures on longitudinal sections of those nerves in
which the fibers could be visualized clearly after neurobiotin injection. We calculated the ODR between OD at the border of fibers and
OD at a more proximal position, within a maximum distance of 300 µm
(see Materials and Methods). ODR values greater than one are indicative
of an increase in the number of fibers along the major axis of the
nerve and thus are suggestive of sprouting. ODR values were calculated
for all the six experimental groups: wt crush, bcl-2 crush, wt HRP,
bcl-2 HRP, wt IN-1, and bcl-2 IN-1. Results are summarized in Figure
8.

View larger version (29K):
[in this window]
[in a new window]
|
Figure 8.
Semiquantitative analysis of fiber responses in
different experimental conditions. Top shows the wt
groups; bottom shows the bcl-2. Columns
represent average OD ratios with standard errors. The
asterisk points out the significant difference among the
bcl-2 IN-1 group and the remaining two.
|
|
In the wt crush group, ODR was 0.87 ± 0.07, and it was not
significantly different from that of the bcl-2 crush group (0.99 ± 0.05; p = 0.06; Mann-Whitney rank sum test).
ODR values among the three groups of wt mice (wt crush, wt HRP, and wt
IN-1) were also very similar and not statistically different
(p = 0.076; Kruskal-Wallis one-way ANOVA). In
contrast, in the three groups of bcl-2 animals (bcl-2 crush, bcl-2 HRP, and bcl-2 IN-1), ODR values were statistically different
(p = 0.001; one-way ANOVA on ranks). To isolate
the groups that differed from the others, we performed a post
hoc group-to-group comparison using the Mann-Whitney rank sum
test. We obtained that there was no significant difference between
bcl-2 HRP and bcl-2 crush (p = 0.451), whereas
bcl-2 IN-1 differed from both bcl-2 crush and bcl-2 HRP
(p = 0.001 in both cases). Thus, densitometric
analysis confirms that sprouting is promoted only in bcl-2 animals
treated with IN-1.
 |
DISCUSSION |
The aim of this study was to evaluate the capabilities of adult
RGCs overexpressing the anti-apoptotic protein bcl-2 to regenerate their injured axons within an environment made more permissive to
axonal elongation.
To test such potentials in an in vivo model, we made use of
bcl-2 transgenic mice treated with IN-1 antibodies.
In previous work (Cenni et al., 1996 ), we described the powerful effect
of bcl-2 overexpression in rescuing RGCs from death induced by
intracranial optic nerve cut. Whereas only 5% RGCs survived in wt
mouse 2 months after the lesion, 63% RGCs were still alive and
functional 3 months after the lesion (Porciatti et al., 1996 ) in the
transgenic animal.
In the present study, an intracranial crush instead of a transection of
the optic nerve was performed. Crush was adopted because it allows
axotomy of RGCs while ensuring the preservation of the optic nerve
connective sheaths, which can act as a scaffold for possibly
regenerating fibers.
First, we estimated the number of RGCs surviving optic nerve crush in
the bcl-2 and in the wt. Similar to what observed after optic nerve
transection, a large difference between bcl-2 and wt mice was found; 1 month after surgery, virtually the whole population of retinal ganglion
cells survived in the bcl-2, whereas 44% remained in the wt retina.
The RGC survival rate that we have estimated in the adult wt mouse 1 month after crush is inferior to the 80% value estimated for the adult
rat, at the same time and after the same lesion (Berkelaar et al.,
1994 ). In the mouse, the intracranial crush of the optic nerve produces
shorter proximal axonal stumps compared with the rat. Because resilient
axonal segments can be considered as a source of factors promoting the
survival of retinal ganglion cells, it can be postulated that, in our
experimental conditions, axotomized RGCs can benefit from a more
limited supply of trophic molecules compared with RGCs of the rat.
We studied the morphology of the axotomized fibers in both transversal
and longitudinal sections. At the optic nerve head, most of the fibers
were well preserved, especially in bcl-2 mice. At more distal
positions, very close to the lesion area, morphology was profoundly
affected, and the number of degenerating profiles increased evidently.
So, fibers retracted from the immediate proximity of the site of crush
in both wt and bcl-2.
Compared with the results reported in previous work (Cenni et al.,
1996 ; Chierzi et al., 1998 ), these observations show that the
difference between wt and bcl-2 is less pronounced after crush than
after cut of the optic nerve. Actually, previous work refers to the
effects of optic nerve cut 2-3 months after surgery. At this time, the
optic nerve head of the wt contains so few fibers that the difference
with bcl-2 is striking. Such protective effects of bcl-2 appear less
dramatic 1 month after crush, when degeneration of both cell bodies and
fibers in the wt is still moderate. Hence, the present results are not
readily comparable with those of the previous work for two reasons: (1)
here, we performed a crush instead of a cut of the optic nerve; and (2)
we choose a survival time of 1 month to limit loss of antibody
production by transplanted hybridoma cells.
Two main conclusions emerge clearly from our data. The first is that
regeneration in the CNS is not substantially facilitated in the
IN-1-treated bcl-2 animals in which only sprouting appears to be
definitely more abundant than in wild-type controls.
This conclusion is unfortunately negative and somewhat contrary to
expectations in that the absence of degeneration of RGCs after crush of
the optic nerve and the block of myelin-derived inhibitory factors
through the administration of IN-1 fulfilled at least two necessary
conditions for regeneration to occur.
The second conclusion concerns the relevance that the hostility of the
CNS to regeneration plays in an in vivo system; experiments in vitro have given evidence that bcl-2 overexpressing
neurons can indeed regenerate over a permissive substrate (Chen et al., 1997 ). Conclusions or generalizations from the in vitro
experiments could be somehow hazardous and misleading when applied to
the in vivo condition.
Our results show that the administration of IN-1 in both the wild-type
and the bcl-2 mouse optic nerve is not sufficient to allow significant
regeneration of transected fibers beyond the site of crush. Injection
of IN-1-producing hybridoma cells on the crushed nerve has been
used by Weibel et al. (1994) to induce regeneration of transected RGC
axons. They implanted IN-1-producing hybridoma cells over the crushed
optic nerves of rats that had received FGF into the vitreous and
observed long-distance regeneration of few axotomized fibers. However,
the experimental design of Weibel et al. differs from the one used in
the present study in some relevant aspects; they injected fibroblast
growth factor to prevent RGC death and axonal degeneration, whereas in
our experimental protocol, both these effects were prevented by
overexpression of bcl-2. Furthermore, the animals used were relatively
immature (16- to 18-d-old), whereas we used adult mice. This difference might be relevant in the amount of regeneration occurring afterward, because it is well known that lesioned fibers of the immature CNS show
a more pronounced attitude to sprouting and regeneration compared with
fibers of the mature CNS (Bates and Stelzner, 1993 ).
The possibility exists that the concentration reached by the IN-1
antibody was not high enough to counteract the inhibitory action of
myelin, although we used relatively large amounts of hybridoma cells
directly at the crush site. It is well known that even very low
concentrations of myelin can arrest growth cone progression in
vitro. Because IN-1 hybridoma cells did not migrate in the distal
stump of the optic nerves in which degenerating myelin persists for a
long time, we can be confident that the effects of myelin inhibitors
have been counteracted within the immediate proximity of the crush
site. Indeed, this is confirmed by the observation that sprouting was
promoted by IN-1 hybridoma cells in bcl-2.
In addition, the failure of the majority of axons to regenerate in the
IN-1-treated bcl-2 mice can be explained by postulating that other
inhibitory factors in addition to myelin proteins are present at the
lesion site.
In particular, the formation of a scar, a process involving different
cell types of the nervous and immune systems (activated astrocytes,
activated microglia, meningeal cells, and inflammatory macrophages and
leukocytes) is believed to play an important role in creating a hostile
environment to regeneration. Indeed, we observed macrophage
concentration at the crush site after hybridoma injection, in both wt
and bcl-2. In the crushed optic nerve, the scar is extending across the
whole nerve thickness; regenerating fibers have to grow through a
region of greatly modified and rearranged tissue, because no bridges of
intact optic nerve remain for their passage. Different lines of
evidence have pointed to reactive astrocytes of the scar as powerful
elements impeding axonal regrowth (McKeon et al., 1995 ; Davies et al.,
1997 ). Reaction of astrocytes to injury results in morphological
hypertrophy and in the synthesis and secretion in the extracellular
matrix of inhibitory molecules, such as the proteoglycan chondroitin
sulfate (McKeon et al., 1995 ). Reactive astrocytes taken from the
crushed optic nerves of rats represent a nonpermissive substrate for
the elongation of CNS axons (Bähr et al., 1995 ).
Even if in our experimental model the axons failed to elongate beyond
the crush site, in bcl-2 mice injected with IN-1-producing hybridoma
cells, we observed axonal sprouting at the border of transected fibers.
We tried to express quantitatively the extent of sprouting observed in
the different experimental cases calculating optical density ratios at
the lesion site for different experimental protocols. We find that, in
wt animals, no treatment is able to increase significantly ODRs,
whereas in bcl-2 mice, the injection of IN-1-producing hybridoma cells
induces a significant increase in ODRs, indicating an effect in
promoting sprouting.
It appears that the administration of IN-1 antibodies to the crushed
optic nerve can unmask an effect of bcl-2 in eliciting the sprouting of
transected fibers.
These results suggest a correlation between bcl-2 overexpression and
axonal growth in an adult animal. Such effect of bcl-2, distinct from
the well known survival effect, is in agreement with some recent
findings: embryonic retinal ganglion cells (embryonic day 18)
from bcl-2 mice have been shown to retain elongation capabilities typical of earlier stages of development, which are absent in RGCs of
wt mice of the same age (Chen et al., 1997 ). In addition, neurons
transfected with the bcl-2 gene show an increase in the outgrowth of
neuritic processes (Zhang et al., 1996 ; Middleton et al., 1998 ). Our
results also correlate with recent studies on the expression of the
endogenous bcl-2 gene in primate brain: the Bcl-2 protein, expressed
diffusely during brain development, becomes restricted in adult life to
distinct structures of the CNS, characterized by persistent plasticity
(Bernier and Parent, 1998 ).
Although the mechanisms of action of bcl-2 are not well clarified, some
hypothesis can be formulated to explain a possible permissive action of
the transgene overexpression on axonal sprouting, in the presence of
IN-1. It is known that the effect of the CNS myelin protein NI 250 (inhibited by IN-1 antibodies) in mediating growth cone collapse is
associated with a large increase in cytosolic calcium released from
intracellular stores. The administration of IN-1 antibodies inhibits
growth cone collapse and prevents the increase in cytosolic calcium
(Bandtlow et al., 1993 ). The Bcl-2 protein is involved in the control
of the calcium homeostasis as well; the protein, localized on the
membrane of intracellular organelles, such as endoplasmic reticulum,
nucleus, and mitochondria, is capable of preventing Ca efflux from such
stores to the cytoplasm in response to apoptotic stimuli (Lam, 1994 ;
Guo et al., 1997 ; Miller, 1998 ). Thus, it is conceivable that IN-1
administration and bcl-2 overexpression can act synergistically, both
limiting the increase of calcium levels associated with growth cone
arrest. When IN-1 antibodies alleviate the strong inhibition exerted by myelin, bcl-2 fibers are able to sprout.
 |
FOOTNOTES |
Received Dec. 21, 1998; revised July 14, 1999; accepted July 16, 1999.
This work was partially supported by the European Economic Community
(Biotech Grant BIO4-CT96-0774) and by the TeleThon Foundation Project
934. We are indebted to Dr. Martin E. Schwab for the IN-1 and HRP
hybridoma cells. We thank Dr. GianMichele Ratto and Dr. Tommaso
Pizzorusso for helpful comments on this manuscript; Dr. Elena Putignano
for performing PCR; and the staff of the Istituto di Neurofisiologia
for technical support.
Drs. Chierzi and Strettoi contributed equally to this work.
Correspondence should be addressed to Enrica Strettoi, Istituto di
Neurofisiologia del Consiglio Nazionale delle Ricerche, Via San Zeno
51, 56127 Pisa, Italy.
 |
REFERENCES |
-
Adams JM,
Cory S
(1998)
The bcl-2 protein family: arbiters of cell survival.
Science
281:1322-1326[Abstract/Free Full Text].
-
Allsopp TE,
Wyatt S,
Patterson HF,
Davies AM
(1993)
The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis.
Cell
73:295-307[Web of Science][Medline].
-
Austyn JM,
Gordon S
(1981)
F4/80, a monoclonal antibody directed specifically against the mouse macrophage.
Eur J Immunol
11:805-815[Web of Science][Medline].
-
Bähr M,
Przyrembel C,
Bastmeyer M
(1995)
Astrocytes from adult rat optic nerves are nonpermissive for regenerating retinal ganglion cell axons.
Exp Neurol
131:211-220[Web of Science][Medline].
-
Bandtlow CE,
Schmidt MF,
Hassinger TD,
Schwab ME,
Kater SB
(1993)
Role of intracellular calcium in NI-35-evoked collapse of neuronal growth cones.
Science
259:80-83[Abstract/Free Full Text].
-
Bates CA,
Stelzner DJ
(1993)
Extension and regeneration of corticospinal axons after early spinal injury and the maintenance of corticospinal topography.
Exp Neurol
123:106-117[Web of Science][Medline].
-
Berkelaar M,
Clarke DB,
Wang Y-C,
Bray GM,
Aguayo AJ
(1994)
Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats.
J Neurosci
14:4368-4374[Abstract].
-
Bernier PJ,
Parent A
(1998)
Bcl-2 protein as a marker of neuronal immaturity in postnatal primate brain.
J Neurosci
18:2486-2497[Abstract/Free Full Text].
-
Berry M,
Carlile J,
Hunter H
(1996)
Peripheral nerve explants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve.
J Neurocytol
25:147-170[Web of Science][Medline].
-
Bonfanti L,
Strettoi E,
Chierzi S,
Cenni MC,
Liu X-H,
Martinou J-C,
Maffei L,
Rabacchi SA
(1996)
Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2.
J Neurosci
16:4186-4194[Abstract/Free Full Text].
-
Brösamle C,
Schwab ME
(1996)
Axonal regeneration in the mammalian CNS.
Semin Neurosci
8:107-113.
-
Burne JF,
Staple JK,
Raff M
(1996)
Glial cells are increased proportionally in transgenic optic nerves with increased numbers of axons.
J Neurosci
16:2064-2073[Abstract/Free Full Text].
-
Carmignoto G,
Maffei L,
Candeo P,
Canella R,
Comelli C
(1989)
Effects of NGF on the survival of rat retinal ganglion cells following optic nerve section.
J Neurosci
9:1263-1272[Abstract].
-
Caroni P,
Schwab ME
(1988)
Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter.
Neuron
1:85-96[Web of Science][Medline].
-
Cenni MC,
Bonfanti L,
Martinou J-C,
Ratto GM,
Strettoi E,
Maffei L
(1996)
Long-term survival of retinal ganglion cells following optic nerve section in adult bcl-2 transgenic mice.
Eur J Neurosci
8:1735-1745[Web of Science][Medline].
-
Chen DF,
Schneider GE,
Martinou J-C,
Tonegawa S
(1997)
bcl-2 promotes regeneration of severed axons in mammalian CNS.
Nature
385:434-439[Medline].
-
Chierzi S,
Cenni MC,
Maffei L,
Pizzorusso T,
Porciatti V,
Ratto GM,
Strettoi E
(1998)
Protection of retinal ganglion cells and preservation of function after optic nerve lesion in bcl-2 transgenic mice.
Vision Res
38:1537-1543[Web of Science][Medline].
-
Davies SJA,
Fitch MT,
Memberg SP,
Hall AK,
Raisman G,
Silver J
(1997)
Regeneration of adult axons in white matter tracts of the central nervous system.
Nature
390:680-683[Medline].
-
Foster GA,
Dahl D,
Lee VMY
(1987)
Temporal and topographic relationship between the phosphorylated and nonphosphorylated epitopes of the 200 kDa neurofilament protein during development in vitro.
J Neurosci
7:2651-2663[Abstract].
-
Guo Q,
Sopher BL,
Furukawa K,
Pham DG,
Robinson N,
Martin GM,
Mattson MP
(1997)
Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid peptide: involvement of calcium and oxyradicals.
J Neurosci
17:4212-4222[Abstract/Free Full Text].
-
Hilton M,
Middleton G,
Davies AM
(1997)
Bcl-2 influences axonal growth rate in embryonic sensory neurons.
Curr Biol
7:798-800[Web of Science][Medline].
-
Jeon CJ,
Strettoi E,
Masland RH
(1998)
the major cell populations of the mouse retina.
J Neurosci
18:8936-8946[Abstract/Free Full Text].
-
Lam M,
Dubyak G,
Chen L,
Nunez G,
Miesfeld RL,
Distelhorst CW
(1994)
Evidence that Bcl-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes.
Proc Natl Acad Sci USA
91:6569-6573[Abstract/Free Full Text].
-
Lawson LJ,
Frost L,
Risbridger J,
Fearn S,
Perry VH
(1994)
Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve.
J Neurocytol
23:729-744[Web of Science][Medline].
-
Maffei L,
Carmignoto G,
Perry VH,
Candeo P,
Ferrari G
(1990)
Schwann cells promote the survival of rat retinal ganglion cells after optic nerve section.
Proc Natl Acad Sci USA
87:1855-1859[Abstract/Free Full Text].
-
Mansour-Robaey S,
Clarke DB,
Wang YC,
Bray GM,
Aguayo AJ
(1994)
Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells.
Proc Natl Acad Sci USA
91:1632-1636[Abstract/Free Full Text].
-
Martinou J-C,
Dubois-Dauphin M,
Staple J,
Rodriguez I,
Frankowski H,
Missoten M,
Albertini P,
Talabot D,
Catsicas S,
Pietra C,
Huarte J
(1994)
Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia.
Neuron
13:1017-1030[Web of Science][Medline].
-
McKeon RJ,
Hoke A,
Silver J
(1995)
Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars.
Exp Neurol
136:32-43[Web of Science][Medline].
-
Middleton G,
Pin LGP,
Wyatt S,
Davies AM
(1998)
Bcl-2 accelerates the maturation of early sensory neurons.
J Neurosci
18:3344-3350[Abstract/Free Full Text].
-
Miller RJ
(1998)
Mitochondria
the Kraken wakes!
Trends Neurosci
21:95-97[Web of Science][Medline]. -
Porciatti V,
Pizzorusso T,
Cenni MC,
Maffei L
(1996)
The visual response of retinal ganglion cells is not altered by optic nerve transection in transgenic mice overexpressing bcl-2.
Proc Natl Acad Sci USA
93:14955-14959[Abstract/Free Full Text].
-
Thanos S,
Bähr M,
Barde Y-A,
Vanselow J
(1989)
Survival and axonal elongation of adult retinal ganglion cells. In vitro effects of lesioned sciatic nerve and brain-derived neurotrophic factor.
Eur J Neurosci
1:19-26[Web of Science][Medline].
-
Vidal-Sanz M,
Bray GM,
Villegas-Perez MP,
Thanos S,
Aguayo AT
(1987)
Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat.
J Neurosci
7:2894-2909[Abstract].
-
Villegas-Perez MP,
Vidal-Sanz M,
Bray GM,
Aguayo AJ
(1988)
Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats.
J Neurosci
8:265-280[Abstract].
-
Weibel D,
Cadelli D,
Schwab ME
(1994)
Regeneration of lesioned rat optic nerve fibers is improved after neutralization of myelin-associated neurite growth inhibitors.
Brain Res
642:259-266[Web of Science][Medline].
-
Zhang KZ,
Westberg JA,
Holtta E,
Andersson LC
(1996)
Bcl-2 regulates neuronal differentiation.
Proc Natl Acad Sci USA
93:4504-4508[Abstract/Free Full Text].
-
Zhong LT,
Sarafian T,
Kane D,
Charles A,
Mah S,
Edwards R,
Bredsen D
(1993)
Bcl-2 inhibits death of central neural cells induced by multiple agents.
Proc Natl Acad Sci USA
90:4533-4537[Abstract/Free Full Text].
Copyright © 1999 Society for Neuroscience 0270-6474/99/19198367-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
K.-S. Cho, L. Yang, B. Lu, H. Feng Ma, X. Huang, M. Pekny, and D. F. Chen
Re-establishing the regenerative potential of central nervous system axons in postnatal mice
J. Cell Sci.,
March 1, 2005;
118(5):
863 - 872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fischer, V. Petkova, S. Thanos, and L. I. Benowitz
Switching Mature Retinal Ganglion Cells to a Robust Growth State In Vivo: Gene Expression and Synergy with RhoA Inactivation
J. Neurosci.,
October 6, 2004;
24(40):
8726 - 8740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-Y. Wu, J.-Q. Zheng, M. A. McDonald, B. Chang, and J. L. Twiss
PKC Isozymes in the Enhanced Regrowth of Retinal Neurites after Optic Nerve Injury
Invest. Ophthalmol. Vis. Sci.,
June 1, 2003;
44(6):
2783 - 2790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Goldberg
How does an axon grow?
Genes & Dev.,
April 15, 2003;
17(8):
941 - 958.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yin, Q. Cui, Y. Li, N. Irwin, D. Fischer, A. R. Harvey, and L. I. Benowitz
Macrophage-Derived Factors Stimulate Optic Nerve Regeneration
J. Neurosci.,
March 15, 2003;
23(6):
2284 - 2293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Huang, D.-Y. Wu, G. Chen, H. Manji, and D. F. Chen
Support of Retinal Ganglion Cell Survival and Axon Regeneration by Lithium through a Bcl-2-Dependent Mechanism
Invest. Ophthalmol. Vis. Sci.,
January 1, 2003;
44(1):
347 - 354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Inoue, M. Hosokawa, K. Morigiwa, Y. Ohashi, and Y. Fukuda
Bcl-2 Overexpression Does Not Enhance In Vivo Axonal Regeneration of Retinal Ganglion Cells after Peripheral Nerve Transplantation in Adult Mice
J. Neurosci.,
June 1, 2002;
22(11):
4468 - 4477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Cai, J. Qiu, Z. Cao, M. McAtee, B. S. Bregman, and M. T. Filbin
Neuronal Cyclic AMP Controls the Developmental Loss in Ability of Axons to Regenerate
J. Neurosci.,
July 1, 2001;
21(13):
4731 - 4739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fischer, M. Pavlidis, and S. Thanos
Cataractogenic Lens Injury Prevents Traumatic Ganglion Cell Death and Promotes Axonal Regeneration Both In Vivo and in Culture
Invest. Ophthalmol. Vis. Sci.,
November 1, 2000;
41(12):
3943 - 3954.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Leon, Y. Yin, J. Nguyen, N. Irwin, and L. I. Benowitz
Lens Injury Stimulates Axon Regeneration in the Mature Rat Optic Nerve
J. Neurosci.,
June 15, 2000;
20(12):
4615 - 4626.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|